Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix B Engel

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
Cytokine|June 15, 2013
TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophyTatyana Novoyatleva, Wiebke Janssen, Astrid Wietelmann, et al.
Cardiovascular Research|December 4, 2009
E2F4 is required for cardiomyocyte proliferationMachteld J van Amerongen, Florian Diehl, Tatyana Novoyatleva, et al.
Plos One|December 19, 2013
Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through VEGF-A/VEGFR-2 signaling pathwayBalaji Samikannu, Chunguang Chen, Neelam Lingwal, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2006
FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarctionFelix B Engel, Patrick C H Hsieh, Richard T Lee, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 28, 2014
FGF1-mediated cardiomyocyte cell cycle reentry depends on the interaction of FGFR-1 and Fn14Tatyana Novoyatleva, Amna Sajjad, Denys Pogoryelov, et al.
Frontiers in Cardiovascular Medicine|October 13, 2022
Live cell screening identifies glycosides as enhancers of cardiomyocyte cell cycle activityAjit Magadum, Harsha V Renikunta, Neha Singh, et al.
Molecular and Cellular Biology|January 2, 2003
p21(CIP1) Controls proliferating cell nuclear antigen level in adult cardiomyocytesFelix B Engel, Ludger Hauck, Manfred Boehm, et al.
Plos One|December 5, 2024
Protease-activated receptor 2 deficient mice develop less angiotensin II induced left ventricular hypertrophy but more cardiac fibrosisAlbrecht Meyer Zu Schwabedissen, Silvia Vergarajauregui, Marko Bertog, et al.
Advanced Healthcare Materials|September 9, 2021
CHIR99021 Promotes hiPSC-Derived Cardiomyocyte Proliferation in Engineered 3D MicrotissuesRamona Hesselbarth, Tilman U Esser, Kaveh Roshanbinfar, et al.
Scientific Reports|May 31, 2020
Recombinant spider silk protein eADF4(C16)-RGD coatings are suitable for cardiac tissue engineeringJohannes P M Kramer, Tamara B Aigner, Jana Petzold, et al.
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Cytokine|June 15, 2013
TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophyTatyana Novoyatleva, Wiebke Janssen, Astrid Wietelmann, et al.
Cardiovascular Research|December 4, 2009
E2F4 is required for cardiomyocyte proliferationMachteld J van Amerongen, Florian Diehl, Tatyana Novoyatleva, et al.
Plos One|December 19, 2013
Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through VEGF-A/VEGFR-2 signaling pathwayBalaji Samikannu, Chunguang Chen, Neelam Lingwal, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2006
FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarctionFelix B Engel, Patrick C H Hsieh, Richard T Lee, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 28, 2014
FGF1-mediated cardiomyocyte cell cycle reentry depends on the interaction of FGFR-1 and Fn14Tatyana Novoyatleva, Amna Sajjad, Denys Pogoryelov, et al.
Frontiers in Cardiovascular Medicine|October 13, 2022
Live cell screening identifies glycosides as enhancers of cardiomyocyte cell cycle activityAjit Magadum, Harsha V Renikunta, Neha Singh, et al.
Molecular and Cellular Biology|January 2, 2003
p21(CIP1) Controls proliferating cell nuclear antigen level in adult cardiomyocytesFelix B Engel, Ludger Hauck, Manfred Boehm, et al.
Plos One|December 5, 2024
Protease-activated receptor 2 deficient mice develop less angiotensin II induced left ventricular hypertrophy but more cardiac fibrosisAlbrecht Meyer Zu Schwabedissen, Silvia Vergarajauregui, Marko Bertog, et al.
Advanced Healthcare Materials|September 9, 2021
CHIR99021 Promotes hiPSC-Derived Cardiomyocyte Proliferation in Engineered 3D MicrotissuesRamona Hesselbarth, Tilman U Esser, Kaveh Roshanbinfar, et al.
Scientific Reports|May 31, 2020
Recombinant spider silk protein eADF4(C16)-RGD coatings are suitable for cardiac tissue engineeringJohannes P M Kramer, Tamara B Aigner, Jana Petzold, et al.
Pageof 11